Schedule 13G ownership disclosure
ZIOPHARM ONCOLOGY INC
Security class unavailable · CUSIP: 98973P101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,331,104
- Percent of class
- 5.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001804350-20-000001
- Form type
- SC 13G
- Filer
- Hardie Robert D.
- CIK
- CIK 1804350
- Filed
- Feb 24, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership